(Q61975745)
Statements
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy (English)
0 references
24 September 2013
0 references
12 January 2016
0 references
1,246
0 references
18 year
0 references
80 year
0 references